Kathryn Susan Prickett

USPTO Granted Patents = 38 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 3)

Average Co-Inventor Count = 3.0

ph-index = 26

Forward Citations = 1,847(Granted Patents)

Location History:

San Francisco, CA (US) (2010)
Hillsborough, CA (US) (2010)
San Diego, CA (US) (1996 - 2013)
Foster City, CA (US) (2011 - 2014)

Company Filing History:

37 out of 164

Amylin Pharmaceuticals, Inc.

patents

6 out of 38

Astrazeneca Pharmaceuticals LP

patents

1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2014

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8906849 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same (2014-12-09),

2. 8759291 - Methods of treatment using exendin peptides or GLP-1 peptides (2014-06-24),

3. 8603969 - Pancreatic polypeptide family motifs and polypeptides comprising the same (2013-12-10),

4. 8598120 - Methods for treatment using amylin family peptides (2013-12-03),

5. 8445647 - Modified exendins and exendin agonists (2013-05-21),

6. 8426361 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same (2013-04-23),

7. 8263550 - Exendin agonist compounds (2012-09-11),

8. 8114958 - Amylin family peptides (2012-02-14),

9. 8057822 - Modified exendins and exendin agonists (2011-11-15),

10. 7960341 - Methods and compositions for treating polycystic ovary syndrome (2011-06-14),

11. 7928065 - Methods of treatment using exendin peptides or GLP-1 peptides (2011-04-19),

12. 7858740 - Exendin agonist compounds (2010-12-28),

13. 7723471 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same (2010-05-25),

14. 7700549 - Exendin agonist analogs to treat diabetes (2010-04-20),

15. 7696161 - Exendin agonist compounds (2010-04-13),

Title: The Innovative Journey of Kathryn Susan Prickett

Introduction

Kathryn Susan Prickett, based in San Diego, California, is a prolific inventor with 38 patents to her name. Her groundbreaking work in the medical field, particularly related to peptides and treatment methods, has significantly contributed to advancements in healthcare.

Latest Patents

Among her most recent patents, Kathryn has innovated in the realm of pancreatic polypeptide family motifs. Her invention provides novel Pancreatic Polypeptide Family (PPF) polypeptides and methods for their application. Additionally, Kathryn has developed methods that increase urine flow through the administration of GLP-1 or exendin peptides. These methods are pivotal for treating a variety of conditions associated with toxic hypervolemia, including renal failure and congestive heart failure. Furthermore, her research delves into pharmaceutical compositions that aid in inducing an inotropic response, enhancing cardiac contractility in patients with specific disorders.

Career Highlights

Kathryn has had an impressive career with noteworthy positions at Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. Her tenure at these companies has enabled her to hone her skills in drug development and innovation in medicinal therapies.

Collaborations

Throughout her career, Kathryn has collaborated with esteemed colleagues such as Andrew A Young and Nigel Robert Arnold Beeley. These partnerships have furthered her research efforts and led to substantial contributions to the biomedical field.

Conclusion

In summary, Kathryn Susan Prickett's contributions to the field of medicine through her innovative patents and collaborations have paved the way for new treatments and methodologies. Her ongoing commitment to research and development continues to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.